Last $9.95 USD
Change Today -0.05 / -0.50%
Volume 16.0K
CDNA On Other Exchanges
As of 2:50 PM 07/28/14 All times are local (Market data is delayed by at least 15 minutes).

caredx inc (CDNA) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/23/14 - $10.20
52 Week Low
07/18/14 - $8.49
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CAREDX INC (CDNA)

Related News

No related news articles were found.

caredx inc (CDNA) Related Businessweek News

No Related Businessweek News Found

caredx inc (CDNA) Details

CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient’s lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, California.

55 Employees
Last Reported Date: 07/18/14
Founded in 1998

caredx inc (CDNA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $350.0K
Chief Medical Officer and Executive Vice Pres...
Total Annual Compensation: $365.7K
Chief Compliance Officer and Chief Business O...
Total Annual Compensation: $308.3K
Compensation as of Fiscal Year 2013.

caredx inc (CDNA) Key Developments

CareDx, Inc(NasdaqGM:CDNA) added to NASDAQ Composite Index

CareDx, Inc will be added to the NASDAQ Composite Index.

CareDx Seeks Acquisitions

CareDx, Inc. has filed an IPO in the amount of $50 million. CareDx intends to use the net proceeds from offering for research and development, including research aimed at expanding the clinical utility of AlloMap and the development of new solutions for the surveillance of heart and kidney transplant recipients, for sales and marketing activities, including expansion of our sales force to support the ongoing commercialization of our products and remainder for general and administrative expenses (including personnel related costs and the costs of operating as a public company), and for working capital and other general corporate purposes. CareDx may also use a portion of the net proceeds from this offering for the acquisition of, or investment in, technologies, solutions or businesses that complement our business.

XDx, Inc. Presents at 16th Annual BIO CEO & Investor Conference 2014, Feb-11-2014 11:45 AM

XDx, Inc. Presents at 16th Annual BIO CEO & Investor Conference 2014, Feb-11-2014 11:45 AM. Venue: The Waldorf-Astoria Hotel, Conrad Room, New York, New York, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDNA:US $9.95 USD -0.05

CDNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CDNA.
View Industry Companies

Industry Analysis


Industry Average

Valuation CDNA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAREDX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at